Sjogren-Larsson Syndrome is a rare genetic condition. It causes a severe skin rash called ichthyosis, which makes the skin very dry and scaly. It also leads to mental disability and muscle stiffness (spasticity), which can cause difficulty walking. This syndrome is caused by a change in a specific gene.
Every report comes from a Lived member, sent anonymously.
Have you tried Moisturizers for Sjogren-Larsson Syndrome?
Sjögren-Larsson syndrome (SLS) is a rare inherited condition in which the body cannot properly break down certain fats. It affects the skin, the brain and spinal cord, and the eyes. Its three core features are dry, thickened, scaly skin (ichthyosis), stiffness and tightness in the leg muscles (spasticity), and intellectual disability. Speech is often delayed and slurred, and some people also have seizures. The skin changes are usually present at birth or appear in early infancy, and babies with SLS are often born early. The scaling tends to be most noticeable on the neck, trunk, underarms and the backs of the legs, while the face is usually spared, and it is typically itchy, which helps set it apart from other inherited scaly-skin conditions. Leg stiffness and slow motor development usually become apparent in the first year or two. Severity varies from person to person, even within the same family. Despite the similar name, SLS is unrelated to Sjögren's syndrome, an autoimmune disease of adults that causes dry eyes and a dry mouth.
SLS is caused by changes (variants) in a gene called ALDH3A2. This gene carries the instructions for an enzyme, fatty aldehyde dehydrogenase, that converts fatty substances called fatty aldehydes and fatty alcohols into fatty acids the body can use or clear. When the enzyme does not work, these fats build up inside cells. In the skin, the buildup weakens the outer barrier that holds in water, which leads to scaling. In the brain, it is thought to disturb myelin, the fatty insulation around nerve fibers, which helps explain the movement, learning and speech difficulties. The condition is autosomal recessive: a child is affected only when they inherit a non-working copy of the gene from both parents. Parents who each carry one copy are usually healthy and often have no family history of the disorder. When both parents are carriers, each pregnancy has a 25 percent chance of a child with SLS. The risk is higher when parents are related by blood. Nothing a parent did during pregnancy causes SLS.
SLS may be suspected at birth from the skin changes, and the overall picture is usually clear by about age 3, when the leg stiffness and developmental delays have become evident. Confirming it matters because several other inherited conditions combine scaly skin with nerve problems. Genetic testing that finds disease-causing variants in both copies of the ALDH3A2 gene is the most definitive step. Specialized labs can also measure the enzyme's activity in skin cells or blood cells, or look for abnormal fat breakdown products in urine. Two other findings support the diagnosis. An eye specialist may see tiny shiny crystals in the retina, the light-sensing layer at the back of the eye, often called glistening white dots; they are seen only in SLS but may not appear until after age 3 or 4, and not everyone has them. A brain MRI (magnetic resonance imaging) scan usually shows changes in the white matter, the nerve-fiber regions of the brain. Genetic counseling is recommended once the diagnosis is made, both for the family's understanding and for future pregnancy planning.
There is currently no treatment that corrects the underlying enzyme problem, so care focuses on easing symptoms and supporting development. It usually involves a team that may include a neurologist, dermatologist, eye specialist, orthopedic specialist, and physical, occupational and speech therapists. Skin care aims to restore the skin's barrier and remove excess scale. Regular moisturizers and creams containing urea or other ingredients that loosen scale (keratolytics) are the everyday foundation. For more severe scaling, a dermatologist may consider acitretin, an oral retinoid (a vitamin A-related medicine) that has markedly improved the skin of some people with SLS. Acitretin is not approved for this use, needs regular monitoring, and causes severe birth defects, so it must not be taken during pregnancy or by anyone who could become pregnant within at least 3 years after stopping it. Itching can be hard to relieve; zileuton, an asthma medicine that blocks inflammatory substances called leukotrienes, helped some people in small studies but not in a controlled trial, so it is sometimes tried for a few weeks when itching is severe. For stiffness, early and ongoing physical therapy, stretching and braces help preserve movement and limit fixed joint tightening (contractures). Muscle-relaxing medicines such as baclofen can reduce stiffness, but their side effects often limit how much they help. Some people benefit from a surgically placed pump that delivers baclofen directly into the fluid around the spinal cord, from tendon-lengthening surgery, or from a nerve procedure called dorsal rhizotomy that reduces stiffness by cutting selected nerve roots in the lower spine. Speech and language therapy started early, including communication aids when needed, can improve communication. Special education services support learning. When seizures occur, standard anti-seizure medicines usually control them. Diets lower in long-chain fats have been tried and may help the skin in some people, but they have not shown a convincing effect on the nervous system. Several treatments aimed at the underlying fat buildup are being studied but are not established.
SLS is a lifelong condition, but it is not mainly a disease of steady mental decline. Learning ability is usually in the mild to moderate range of intellectual disability, and studies have not found cognitive decline through at least the first three to four decades of life. Many people reach a level of partial independence in daily activities with the right support. People with SLS typically understand language better than they can speak it, so communication support can make a real difference. Movement is where needs most often change. Some people walk with braces or canes, but many, around half or more, eventually use a wheelchair, and joint tightening can develop without ongoing therapy. Scaling and itching are daily concerns that need a regular skin-care routine, and they can affect sleep and comfort. Ongoing follow-up usually includes developmental and school planning, regular physical therapy, skin care reviews, eye checks and seizure management if needed. Because SLS is rare, families often find it useful to connect with ichthyosis and rare-disease organizations and to plan early for school support, mobility equipment and long-term care.
Ask for an evaluation if a baby or young child has scaly, itchy skin from birth together with stiff legs or slow motor development, or if a family already has a child with SLS and is planning another pregnancy; genetic counseling can explain testing options. Arrange a timely visit with the care team if stiffness or joint tightening is getting worse, walking or sitting becomes harder, itching is disrupting sleep, or there are new vision complaints. Contact the care team promptly about a first seizure or seizures that become more frequent.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Sjogren-Larsson Syndrome is like, what's helped you, or ask the community a question.